BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 18284310)

  • 1. History of neuroprotection and rationale as a therapy for glaucoma.
    Levin LA; Peeples P
    Am J Manag Care; 2008 Feb; 14(1 Suppl):S11-4. PubMed ID: 18284310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease progression and the need for neuroprotection in glaucoma management.
    Varma R; Peeples P; Walt JG; Bramley TJ
    Am J Manag Care; 2008 Feb; 14(1 Suppl):S15-9. PubMed ID: 18284311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Glaucoma--neurodegenerative disease].
    Tataru LC; Bogdănici CM
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(4):1120-5. PubMed ID: 20191885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent clinical findings with memantine should not mean that the idea of neuroprotection in glaucoma is abandoned.
    Osborne NN
    Acta Ophthalmol; 2009 Jun; 87(4):450-4. PubMed ID: 19141144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optic nerve and neuroprotection strategies.
    Osborne NN; Chidlow G; Layton CJ; Wood JP; Casson RJ; Melena J
    Eye (Lond); 2004 Nov; 18(11):1075-84. PubMed ID: 15534592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular and cell-based approaches for neuroprotection in glaucoma.
    Lebrun-Julien F; Di Polo A
    Optom Vis Sci; 2008 Jun; 85(6):417-24. PubMed ID: 18521011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In glaucoma, should enthusiasm about neuroprotection be tempered by the experience obtained in other neurodegenerative disorders?
    Haefliger IO; Fleischhauer JC; Flammer J
    Eye (Lond); 2000 Jun; 14 ( Pt 3B)():464-72. PubMed ID: 11026975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotection in glaucoma: recent and future directions.
    Danesh-Meyer HV
    Curr Opin Ophthalmol; 2011 Mar; 22(2):78-86. PubMed ID: 21252670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Retinal ganglion cells death in glaucoma--mechanism and potential treatment. Part I].
    Rokicki W; Dorecka M; Romaniuk W
    Klin Oczna; 2007; 109(7-9):349-52. PubMed ID: 18260296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glaucoma as a neurodegenerative disease.
    Gupta N; Yücel YH
    Curr Opin Ophthalmol; 2007 Mar; 18(2):110-4. PubMed ID: 17301611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis of ganglion "cell death" in glaucoma and neuroprotection: focus on ganglion cell axonal mitochondria.
    Osborne NN
    Prog Brain Res; 2008; 173():339-52. PubMed ID: 18929120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical trials in neuroprotection.
    Whitcup SM
    Prog Brain Res; 2008; 173():323-35. PubMed ID: 18929119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotection in glaucoma - Is there a future role?
    Baltmr A; Duggan J; Nizari S; Salt TE; Cordeiro MF
    Exp Eye Res; 2010 Nov; 91(5):554-66. PubMed ID: 20800593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of memantine treatment for reduction of changes associated with experimental glaucoma in monkey, I: Functional measures.
    Hare WA; WoldeMussie E; Lai RK; Ton H; Ruiz G; Chun T; Wheeler L
    Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2625-39. PubMed ID: 15277486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glaucoma of the brain: a disease model for the study of transsynaptic neural degeneration.
    Yücel Y; Gupta N
    Prog Brain Res; 2008; 173():465-78. PubMed ID: 18929128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting excitotoxic/free radical signaling pathways for therapeutic intervention in glaucoma.
    Seki M; Lipton SA
    Prog Brain Res; 2008; 173():495-510. PubMed ID: 18929130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current understanding of neuroprotection in glaucoma.
    Wein FB; Levin LA
    Curr Opin Ophthalmol; 2002 Apr; 13(2):61-7. PubMed ID: 11880717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neuroprotection in glaucoma].
    Kuprjanowicz L; Karczewicz D
    Ann Acad Med Stetin; 2007; 53 Suppl 1():22-9. PubMed ID: 19425476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinal ganglion cell death in glaucoma: mechanisms and neuroprotective strategies.
    Kuehn MH; Fingert JH; Kwon YH
    Ophthalmol Clin North Am; 2005 Sep; 18(3):383-95, vi. PubMed ID: 16054996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Glaucoma as primary optic neuropathy].
    Nicolae A; Stefan C
    Oftalmologia; 2001; 54(4):5-8. PubMed ID: 12035602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.